The response of circulating omentin-1 concentration to 16-week exercise training in male children with obesity

Physician and Sportsmedicine

Volumn 44, Issue 4, 2016, Pages 355-361

  Zehsaz, Farzad ^a   Farhangi, Negin ^a   Ghahramani, Mehri ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Adipokine; children; exercise training; insulin resistance

Indexed keywords

ADIPOCYTOKINE; CHOLESTEROL; GLUCOSE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMENTIN 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CYTOKINE; GLUCOSE BLOOD LEVEL; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

AEROBIC EXERCISE; ARTICLE; BODY COMPOSITION; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; FAT FREE MASS; FAT MASS; HEART RATE; HUMAN; INSULIN RESISTANCE; MALE; OBESITY; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; SCHOOL CHILD; UPREGULATION; WAIST CIRCUMFERENCE; ADIPOSE TISSUE; BLOOD; BODY WEIGHT; GLUCOSE BLOOD LEVEL; METABOLISM; PHYSIOLOGY;

ADIPOSE TISSUE; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; CHILD; CYTOKINES; EXERCISE; GPI-LINKED PROTEINS; HUMANS; INSULIN; INSULIN RESISTANCE; LECTINS; LIPIDS; MALE; OBESITY; RESISTANCE TRAINING; UP-REGULATION; WAIST CIRCUMFERENCE;

EID: 84994219757     PISSN: 00913847     EISSN: 23263660     Source Type: Journal    
DOI: 10.1080/00913847.2016.1248223     Document Type: Article

References (48)

1. J.S.Huang, S.E.Barlow, R.E.Quiros-Tejeira, et al. Childhood obesity for pediatric gastroenterologists. J Pediatr Gastroenterol Nutr. 2013;56:99–109.
2. J.P.Despres, I.Lemieux Abdominal obesity and metabolic syndrome. Nature. 2006;444:881–887.
3. F.Lago, R.Gomez, J.J.Gomez-Reino, et al. Adipokines as novel modulators of lipid metabolism. Trends Biochem Sci. 2009;34:500–510.
4. V.Van Harmelen, S.Reynisdottir, P.Eriksson, et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes. 1998;47:913–917.
5. J.P.Whitehead, A.A.Richards, I.J.Hickman, et al. Adiponectin–a key adipokine in the metabolic syndrome. Diabetes Obes Metab. 2006;8:264–280.
6. P.Trayhurn, I.S.Wood. Signalling role of adipose tissue:adipokines and inflammation in obesity. Biochem Soc Trans. 2005;33:1078–1081.
7. Y.Wang, K.S.Lam, E.W.Kraegen, et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem. 2007;53:34–41.
8. E.Krusinova, T.Pelikanova. Fatty acid binding proteins in adipose tissue:a promising link between metabolic syndrome and atherosclerosis? Diabetes Res Clin Pract. 2008;82:S127–S34.
9. M.C.Alessi, F.Peiretti, P.Morange, et al. Production of plasminogen activator inhibitor 1 by human adipose tissue:possible link between visceral fat accumulation and vascular disease. Diabetes. 1997;46:860–867.
10. S.K.Fried, D.A.Bunkin, A.S.Greenberg. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6:depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998;83:847–850.
11. T.Auguet, Y.Quintero, D.Riesco, et al. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet. 2011;12:60.
12. M.Ramanjaneya, J.Chen, J.E.Brown, et al. Identification of nesfatin-1 in human and murine adipose tissue:a novel depot-specific adipokine with increased levels in obesity. Endocrinology. 2010;151:3169–3180.
13. T.Komiya, Y.Tanigawa, S.Hirohashi. Cloning of the novel gene intelectin, which is expressed in intestinal paneth cells in mice. Biochem Biophys Res Commun. 1998;251:759–762.
14. R.Z.Yang, M.J.Lee, H.Hu, et al. Identification of omentin as a novel depotspecific adipokine in human adipose tissue:possible role in modulating insulin action. Am J Physiol Endocrinol Metab. 2006;290:E1253–61.
15. B.K.Tan, R.Adya, S.Farhatullah, et al. Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes. 2010;59:3023–3031.
16. Y.Yilmaz, O.Yonal, R.Kurt, et al. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scand J Gastroenterol. 2011;46:91–97.
17. I.Jialal, S.Devaraj, H.Kaur, et al. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab. 2013;98:E514–7.
18. J.M.Moreno-Navarrete, V.Catalán, F.Ortega, et al. Circulating omentin concentration increases after weight loss. Nutr Metab (Lond). 2010;7:27.
19. H.Y.Pan, L.Guo, Q.Li. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract. 2010;88:29–33.
20. B.K.Tan, R.Adya, S.Farhatullah, et al. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome:ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes. 2008;57:801–808.
21. J.Y.Zhou, L.Chan, S.W.Zhou. Omentin:linking metabolic syndrome and cardiovascular disease. Curr Vasc Pharmacol. 2014;12:136–143.
22. D.Stensvold, A.E.Tjønna, E.A.Skaug, et al. Strength training versus aerobic interval training to modify risk factors of metabolic syndrome. J Appl Physiol. 2010;108:804–810.
23. K.H.Schmitz, D.R.JacobsJr, C.P.Hong, et al. Association of physical activity with insulin sensitivity in children. Int J Obes Relat Metab Disord. 2002;26:1310–1316.
24. M.Krekoukia, G.P.Nassis, G.Psarra, et al. Elevated total and central adiposity and low physical activity are associated with insulin resistance in children. Metabolism. 2007;56:206–213.
25. Y.M.Hong, K.R.Moon, J.W.Seo, et al. Guideline of diagnosis and treatment in childhood obesity. J Kor Pediat Soc. 1999;42:1338–45. [In Korean, English Abstract].
26. M.Hamer, A.Steptoe. Prospective study of physical fitness, adiposity and inflammatory markers in healthy middle aged men and women. Am J Clin Nutr. 2009;89:85–89.
27. M.Gleeson, N.C.Bishop, D.J.Stensel, et al. The anti-inflammatory effects of exercise:mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol. 2011;11:607–615.
28. C.Riddoch. Relationships between physical activity and physical health in young people. In:S.Biddle, J.Sallis, N.Cavill, editors. Young and active? Young people and health enhancing physical activity:evidence and implications. London:HEA; 1998. p. 17–48.
29. A.Saremi, M.Asghari, A.Ghorbani. Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men. J Sports Sci. 2010;28:993–998.
30. J.Y.Jeon, J.Han, H.J.Kim, et al. The combined effects of physical exercise training and detraining on adiponectin in overweight and obese children. Integr Med Res. 2013;2:145–150.
31. L.B.Houtkooper, T.G.Lohman, S.B.Going, et al. Validity of bioelectric impedance for body composition assessment in children. J Appl Physiol. 1989;66:814–821.
32. D.Docherty, ed. Measurement in pediatric exercise science. Champaign (IL):Human Kinetics; 1996.
33. B.Wilms, B.Ernst, R.Gerig, et al. Plasma omentin-1 levels are related to exercise performance in obese women and increase upon aerobic endurance training. Exp Clin Endocrinol Diabetes. 2015 Mar;123(3):187–192. Epub 2015 Mar 19. DOI:10.1055/s-0034-1398504
34. C.M.De Souza Batista, R.Z.Yang, M.J.Lee, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 2007;56:1655–1661.
35. A.Prats-Puig, J.Bassols, E.Bargalló, et al. Toward an early marker of metabolic dysfunction:omentin-1 in prepubertal children. Obesity (Silver Spring). 2011;19:1905–1907.
36. G.Catli, A.Anik, A.Abaci, et al. Low omentin-1 levels are related with clinical and metabolic parameters in obese children. Exp Clin Endocrinol Diabetes. 2013;121:595–600.
37. B.Wilms, B.Ernst, R.Gerig, et al. Plasma omentin-1 levels are related to exercise performance in obese women and increase upon aerobic endurance training. Exp Clin Endocrinol Diabetes. 2015;123:187–192.
38. M.Onstad, K.Basen-Engquist, R.Schmandt, et al. Omentin as a potential biomarker related to exercise and cancer risk. J Clin Oncol. 2015;33(suppl):abstr 1571.
39. S.Suh, I.K.Jeong, M.Y.Kim, et al. Effects of resistance training and aerobic exercise on insulin sensitivity in overweight Korean adolescents:a controlled randomized trial. Diabetes Metab J. 2011;35:418–426.
40. P.Stiegler, A.Cunliffe. The role of diet and exercise for the maintenance of fat-free mass and resting metabolic rate during weight loss. Sports Med. 2006;36:239–262.
41. A.Misra, N.K.Alappan, N.K.Vikram, et al. Effect of supervised progressive resistance-exercise training protocol on insulin sensitivity, glycemia, lipids, and body composition in Asian Indians with type 2 diabetes. Diabetes Care. 2008;31:1282–1287.
42. L.J.Guo, T.J.Jiang, L.Liao, et al. Relationship between serum omentin-1 level and bone mineral density in girls with anorexia nervosa. J Endocrinol Invest. 2013;36:190–194.
43. P.C.Wong, M.Y.Chia, I.Y.Tsou, et al. Effects of a 12-week exercise training programme on aerobic fitness, body composition, blood lipids and C-reactive protein in adolescents with obesity. Ann Acad Med Singapore. 2008;37:286–293.
44. B.Garanty-Bogacka, M.Syrenicz, J.Goral, et al. Changes in inflammatory biomarkers after successful lifestyle intervention in obese children. Endokrynol Pol. 2011;62:499–505.
45. M.Faramarzi, E.Banitalebi, S.Nori, et al. Effects of rhythmic aerobic exercise plus core stability training on serum omentin, chemerin and vaspin levels and insulin resistance of overweight women. J Sports Med Phys Fitness. 2015;56:476–482.
46. M.Urbanová, I.Dostálová, P.Trachta, et al. Serum concentrations and subcutaneous adipose tissue mRNA expression of omentin in morbid obesity and type 2 diabetes mellitus:the effect of very-low-calorie diet, physical activity and laparoscopic sleeve gastrectomy. Physiol Res. 2014;63:207–218.
47. J.Lesná, A.Tichá, R.Hyšpler, et al. Omentin-1 plasma levels and cholesterol metabolism in obese patients with diabetes mellitus type 1:impact of weight reduction. Nutr Diabetes. 2015;5:e183.
48. S.Pilia, M.R.Casini, M.L.Foschini, et al. The effect of puberty on insulin resistance in obese children. J Endocrinol Invest. 2009;32:401–405.